Post COVID Alopecia in the Indian Subcontinent: A Harbinger of Disease Severity

October 2025 in “ Dermatology Practical & Conceptual ”

Anshitha Vurimindi Kadudas, Tina Priscilla, Nihar B. Gala, Anu Mohandas, Manmohan Gavvala, Rishita Pogula, Sai Rashmitha Pagadala, Attipalli Ramachandra Reddy, S Subramanyam

COVID-19-induced alopecia alopecia hair loss

The study investigates the prevalence of COVID-19-induced alopecia in India, finding a prevalence rate of 37.8%. It highlights a significant association between the severity of COVID-19 and the occurrence of alopecia, emphasizing the importance of reviewing patient history to ensure proper treatment and reassurance for affected individuals.

View this study on dpcj.org →

Discuss this study in the Community →

Research cited in this study

23 / 23 results

research A Cross-Sectional Study on Post-Coronavirus Disease Hair Loss at a Tertiary Care Hospital

October 2023 in “Dermatology practical & conceptual”

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

research The Association Between Hair Loss and COVID-19: Impact on Quality of Life in Saudi Arabia

1 citations , October 2022 in “Cureus”

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

research Prevalence of Hair Loss After COVID-19 Infection in Makkah Region, Saudi Arabia

2 citations , September 2022 in “Cureus”

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

research Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium

3 citations , April 2022 in “Clinical, Cosmetic and Investigational Dermatology”

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

research Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication

8 citations , February 2022 in “Journal of Clinical Medicine”

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

research A Systematic Review of Acute Telogen Effluvium, a Harrowing Post-COVID-19 Manifestation

25 citations , December 2021 in “Journal of Medical Virology”

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

research Characteristics of Telogen Effluvium in COVID-19 in Western Iran (2020)

7 citations , September 2021 in “Anais Brasileiros De Dermatologia”

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

research COVID-19 Infection Is a Major Cause of Acute Telogen Effluvium

25 citations , August 2021 in “Irish Journal of Medical Science (1971 -)”

COVID-19 infection can significantly cause temporary hair loss.

Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management

research Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management

39 citations , August 2021 in “JAAD International”

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

research Time of Onset and Duration of Post-COVID-19 Acute Telogen Effluvium

32 citations , July 2021 in “Journal of The American Academy of Dermatology”

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

research Long-Term Post-COVID Symptoms and Associated Risk Factors in Previously Hospitalized Patients: A Multicenter Study

56 citations , May 2021 in “Journal of infection/The Journal of infection”

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

research Post Covid-19 Telogen Effluvium: What Is the Reason?

1 citations , May 2021 in “InterConf”

Post-COVID-19 hair loss is likely due to stress and inflammation.

research Telogen Effluvium Associated with COVID-19 Infection

44 citations , January 2021 in “Dermatologic Therapy”

COVID-19 may cause hair loss due to infection stress or treatments.

research What Can Hair Tell Us About COVID-19?

27 citations , December 2020 in “Experimental Dermatology”

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

research Telogen Effluvium: A Sequela of COVID-19

58 citations , November 2020 in “International Journal of Dermatology”

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

research SARS-CoV-2-Induced Telogen Effluvium: A Multicentric Study

51 citations , November 2020 in “Journal of the European Academy of Dermatology and Venereology”

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

research Post-Discharge Persistent Symptoms and Health-Related Quality of Life After Hospitalization for COVID-19

737 citations , August 2020 in “Journal of Infection”

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

research Relative Changes in the Pattern of Diseases Presenting in Dermatology Outpatient Clinic in the Era of the COVID-19 Pandemic

43 citations , July 2020 in “Dermatologic Therapy”

During the COVID-19 pandemic, a clinic in Turkey saw fewer patients but more cases of certain skin conditions, possibly linked to the virus and stress.

research Evaluation of the Effects of COVID-19 Pandemic on Hair Diseases Through a Web-Based Questionnaire

39 citations , June 2020 in “Dermatologic Therapy”

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

research Management of Telogen Effluvium During the COVID-19 Emergency: Psychological Implications

31 citations , May 2020 in “Dermatologic Therapy”

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

research Covid-19 And Dermatology: A Comprehensive Guide For Dermatologists

36 citations , May 2020 in “Journal of the European Academy of Dermatology and Venereology”

Dermatologists should watch for skin symptoms in COVID-19 patients, prioritize urgent cases, and use telemedicine.

research Telogen Effluvium: A Comprehensive Review

56 citations , August 2019 in “Clinical, Cosmetic and Investigational Dermatology”

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

research Dengue-Associated Telogen Effluvium: A Report of 14 Patients

13 citations , May 2017 in “Dermatologica Sinica”

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

Related Community Posts Join

6 / 467 results

Compressed part of research of theory of androgenic/anabolitic balance. AGA h-responders analytic. Theory of physio-metabolitic method of anti AGA treatment

community Compressed part of research of theory of androgenic/anabolitic balance. AGA h-responders analytic. Theory of physio-metabolitic method of anti AGA treatment

MagicBold in Research 865 upvotes 1 year ago

The treatment for androgenetic alopecia involves using finasteride and minoxidil with intense exercise and cold exposure to boost metabolism and reduce androgenic effects, potentially leading to hair regrowth. This approach may activate biological pathways for improved hair and overall health.

community Covid (likely) induced alopecia areata - now 2nd round of Covid, what can I expect?

in Treatment 1 upvotes 3 years ago

After experiencing hair loss due to alopecia areata following COVID-19 vaccination and infection, the individual saw improvement with steroid treatments and Olumiant. They paused Olumiant during a second COVID-19 infection and expressed concern about potential hair loss flare-ups.

community Hair loss after COVID or vaccination isn’t “made up” but it’s also not what TikTok makes it sound like

in Research/Science 2 upvotes 2 months ago

COVID and COVID vaccination can trigger hair loss, primarily telogen effluvium, due to stress and immune system activation. Proper diagnosis and addressing factors like nutrition and stress are crucial for recovery.

community Study: There is 70x Higher Unconjugated DHT in Feces Compared To Blood Levels in Young Adults - Gut Microbiota Manages DHT Recycling and Metabolism

in Research/Science 194 upvotes 9 months ago

Gut microbiota significantly influences androgen metabolism, impacting hair loss treatments like finasteride. Probiotics, dietary changes, and fecal microbiota transplants may help manage DHT levels and improve hair health.

community Has any premature balding guys actually saved and maintained their hair?

in Chat 17 upvotes 1 year ago

A user discusses their struggle with aggressive hair loss starting at a young age and their use of various treatments, including topical finasteride, minoxidil, dutasteride, and RU58841, without significant success. Other users share their experiences and suggest trying oral finasteride or dutasteride, topical spironolactone, and maintaining a vitamin regimen, while noting potential side effects like gynecomastia.

community It’s getting worse. (4 months)

in Update 203 upvotes 2 years ago

The conversation discusses hair loss treatments, with users suggesting the use of finasteride daily, considering minoxidil for aggressive hair loss, and discussing the normalcy of shedding during treatment. Some users recommend adding Nizoral shampoo and switching to dutasteride for better results.

Similar Research

6 / 1000+ results

Dermatologic Implications of COVID-19 Infection and Immunization: Hair Loss

research Precision Therapeutics in Non-Scarring Alopecia: A Systemic Genomic and Pathway-Based Framework for Targeted Interventions

December 2025 in “ADMET & DMPK”

Personalized treatments for hair loss focus on specific genetic and biological pathways.

research Viral-Induced Rapidly Progressive Alopecia Universalis: A Case Report and Literature Review

April 2023 in “Curēus”

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.